Viridian Therapeutics, Inc.\DE Income Statement (2014-2025) | VRDN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2014	Jun2014	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Dec2016	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	1.48M	1.62M	1.87M	1.51M	1.32M	1.46M	0.50M	0.66M	0.92M	1.11M	0.94M	0.51M	0.46M	0.72M	1.63M	1.19M	4.78M	2.18M	0.94M	0.48M	0.37M	2.51M	0.69M	0.88M	0.83M	0.17M	-0.09M	-0.18M	1.45M	1.09M	0.21M	0.21M	0.22M	0.26M	1.20M	0.10M	0.10M	0.07M	0.07M	0.07M	0.07M	0.07M	0.09M	0.07M	0.07M	0.07M	70.57M
Gross Profit	0.75M	0.67M	0.97M	0.73M	0.56M	0.78M	-0.29M	0.12M	0.29M	0.49M	0.34M	-0.18M
Operating items
Research & Development	0.04M	0.13M	0.10M	0.08M	0.10M	0.19M	0.25M	0.46M	3.47M	3.35M	2.96M	3.91M	4.12M	5.49M	5.02M	5.00M	6.41M	8.38M	7.40M	8.23M	8.75M	8.60M	9.03M	8.42M	6.10M	3.84M	3.11M	15.25M	13.81M	12.56M	8.12M	22.39M	17.75M	21.71M	22.12M	39.32M	50.74M	40.08M	30.39M	38.56M	40.94M	56.19M	69.16M	71.96M	76.83M	86.63M	86.26M
Selling, General & Administrative	0.43M	2.94M	1.76M	1.73M	1.96M	1.78M	2.00M	1.95M	0.99M	1.21M	2.05M	2.52M	3.28M	2.58M	2.50M	2.55M	2.99M	2.67M	2.70M	2.69M	3.36M	2.86M	2.90M	2.53M	2.72M	2.71M	2.30M	5.54M	6.16M	6.52M	6.22M	6.90M	8.36M	8.11M	8.86M	9.85M	21.83M	19.26M	20.91M	32.99M	15.03M	16.07M	14.41M	15.58M	17.10M	20.22M	24.32M
Other Operating Expenses	0.80M	1.02M	1.07M	1.10M	1.19M	1.25M	1.37M	1.21M																				69.86M															-0.20M				0.45M
Operating Expenses	1.26M	4.08M	2.93M	2.91M	3.26M	3.22M	3.63M	3.62M	4.46M	4.57M	5.02M	6.42M	7.40M	8.07M	7.52M	7.55M	9.40M	11.04M	10.10M	10.93M	12.11M	11.46M	11.93M	10.95M	8.83M	6.54M	5.41M	90.65M	19.97M	19.09M	14.34M	29.30M	26.11M	29.82M	30.98M	49.17M	72.57M	59.35M	51.30M	71.55M	55.97M	72.26M	83.57M	87.54M	93.94M	106.84M	110.58M
Operating Income	-0.17M	-2.81M	-1.63M	-2.26M	-2.61M	-2.49M	-3.13M	-2.96M	-3.54M	-3.45M	-4.08M	-5.91M	-6.94M	-7.35M	-5.89M	-6.35M	-4.62M	-8.86M	-9.15M	-10.45M	-11.74M	-8.94M	-11.23M	-10.07M	-8.00M	-6.37M	-5.41M	-90.60M	-18.52M	-18.00M	-14.13M	-29.08M	-25.89M	-29.56M	-29.79M	-49.07M	-72.47M	-59.27M	-51.22M	-71.48M	-55.90M	-72.19M	-83.48M	-87.47M	-93.87M	-106.77M	-40.01M
EBIT	-0.17M	-2.81M	-1.63M	-2.26M	-2.61M	-2.49M	-3.13M	-2.96M	-3.54M	-3.45M	-4.08M	-5.91M	-6.94M	-7.35M	-5.89M	-6.35M	-4.62M	-8.86M	-9.15M	-10.45M	-11.74M	-8.94M	-11.23M	-10.07M	-8.00M	-6.37M	-5.41M	-90.60M	-18.52M	-18.00M	-14.13M	-29.08M	-25.89M	-29.56M	-29.79M	-49.07M	-72.47M	-59.27M	-51.22M	-71.48M	-55.90M	-72.19M	-83.48M	-87.47M	-93.87M	-106.77M	-40.01M
Non-operating items
Interest & Investment Income																														0.06M	0.09M	0.14M	0.20M	0.23M	1.04M	3.45M	4.49M	4.38M	4.16M	5.53M	7.94M	7.79M	7.51M	9.05M	7.54M	6.55M	5.52M
Non Operating Income									0.01M	0.01M	0.01M	0.02M	0.03M	0.10M	0.11M	0.16M	0.17M	0.36M	0.36M	0.36M	0.34M	0.28M	0.20M	0.12M	0.10M	0.03M	0.01M	0.04M	0.06M	0.03M	0.09M	0.14M	0.20M	0.07M	0.88M	3.28M	4.32M	4.21M	3.56M	4.62M	7.36M	7.19M	6.79M	7.75M	6.95M	6.03M	5.41M
Net income details
EBT	-0.71M	-3.29M	-1.64M	-2.26M	-2.63M	-2.56M	-3.15M	-2.98M	-3.63M	-3.53M	-4.16M	-5.99M	-7.01M	-7.41M	-5.95M	-6.54M	-4.83M	-9.07M	-9.37M	-10.68M	-11.97M	-9.17M	-11.43M	-10.24M	-8.14M	-6.47M	-5.50M	-90.78M	-18.52M	-17.94M	-14.04M	-28.95M	-25.69M	-29.49M	-28.91M	-45.78M	-68.15M	-55.06M	-47.66M	-66.86M	-48.54M	-64.99M	-76.49M	-79.78M	-86.91M	-100.73M	-35.05M
Profit After Tax	-0.71M	-0.71M	-1.64M	-2.26M	-2.63M	-2.56M	-3.15M	-2.98M	-3.62M	-3.52M	-4.15M	-5.97M	-6.98M	-7.31M	-5.83M	-6.39M	-4.66M	-8.71M	-9.01M	-10.32M	-11.63M	-8.90M	-11.23M	-10.12M	-8.04M	-6.43M	-5.49M	-90.74M	-18.46M	-17.96M	-14.04M	-28.95M	-25.69M	-29.49M	-28.91M	-45.78M	-68.15M	-55.06M	-47.66M	-66.86M	-48.54M	-64.99M	-76.69M	-79.72M	-86.91M	-100.73M	-34.60M
Income from Continuing Operations	-0.71M	-3.29M	-1.64M	-2.26M	-2.63M	-2.56M	-3.15M	-2.98M	-3.63M	-3.53M	-4.16M	-5.99M	-7.01M	-7.41M	-5.95M	-6.54M	-4.83M	-9.07M	-9.37M	-10.68M	-11.97M	-9.17M	-11.43M	-10.24M	-8.14M	-6.47M	-5.50M	-90.78M	-18.52M	-17.94M	-14.04M	-28.95M	-25.69M	-29.49M	-28.91M	-45.78M	-68.15M	-55.06M	-47.66M	-66.86M	-48.54M	-64.99M	-76.49M	-79.78M	-86.91M	-100.73M	-35.05M
Consolidated Net Income	-0.71M	-3.29M	-1.64M	-2.26M	-2.63M	-2.56M	-3.15M	-2.98M	-3.63M	-3.53M	-4.16M	-5.99M	-7.01M	-7.41M	-5.95M	-6.54M	-4.83M	-9.07M	-9.37M	-10.68M	-11.97M	-9.17M	-11.43M	-10.24M	-8.14M	-6.47M	-5.50M	-90.78M	-18.52M	-17.94M	-14.04M	-28.95M	-25.69M	-29.49M	-28.91M	-45.78M	-68.15M	-55.06M	-47.66M	-66.86M	-48.54M	-64.99M	-76.49M	-79.78M	-86.91M	-100.73M	-35.05M
Income towards Parent Company	-0.71M	-3.29M	-1.64M	-2.26M	-2.63M	-2.56M	-3.15M	-2.98M	-3.63M	-3.53M	-4.16M	-5.99M	-7.01M	-7.41M	-5.95M	-6.54M	-4.83M	-9.07M	-9.37M	-10.68M	-11.97M	-9.17M	-11.43M	-10.24M	-8.14M	-6.47M	-5.50M	-90.78M	-18.52M	-17.94M	-14.04M	-28.95M	-25.69M	-29.49M	-28.91M	-45.78M	-68.15M	-55.06M	-47.66M	-66.86M	-48.54M	-64.99M	-76.49M	-79.78M	-86.91M	-100.73M	-35.05M
Preferred Dividend Payments									-0.01M	0.01M	0.01M	0.01M	0.01M
Net Income towards Common Stockholders	-0.71M	-3.29M	-1.64M	-2.26M	-2.63M	-2.56M	-3.15M	-2.98M	-3.63M	-3.54M	-4.17M	-5.99M	-6.99M	-7.31M	-5.83M	-6.39M	-4.66M	-8.71M	-9.02M	-10.31M	-11.63M	-8.90M	-11.23M	-10.12M	-8.04M	-6.43M	-5.49M	-90.74M	-18.46M	-17.96M	-14.04M	-28.95M	-25.69M	-29.49M	-28.91M	-45.78M	-68.15M	-55.06M	-47.66M	-66.86M	-48.54M	-64.99M	-76.49M	-79.78M	-86.91M	-100.73M	-35.05M
Additional items
EPS (Basic)	-3.53	-4.73	-0.40	-0.09	-0.45	-0.33	-0.39	-19.87	-5.58	-5.88	-6.92	-9.20	-0.60	-0.34	-0.27	-0.29	-0.18	-0.29	-0.29	-0.33	-0.38	-0.29	-0.36	-0.31	-2.65	-1.82	-1.48	-25.31	-2.91	-2.21	-1.25	-0.71	-0.98	-1.06	-0.86	-178.15	-1.61	-1.27	-1.09	-256.73	-39.45	-51.64	-58.99	-54.24	-57.94	-66.99	-22.96
EPS (Weighted Average and Diluted)																										-2.59	-1.48	-25.31	-2.91	-2.21	-1.25	-0.71	-0.98	-1.06	-0.86	-178.15	-1.61	-1.27	-1.09	-256.73	-39.45	-51.64	-58.99	-54.24	-57.94	-66.99	-22.96
Shares Outstanding (Weighted Average)	0.02M	0.02M	0.02M	0.02M	0.03M	0.03M	0.03M	0.05M	0.05M	0.05M	0.05M	0.05M	0.10M	1.43M	1.43M	1.49M	2.01M	2.01M	2.04M	2.06M	2.06M	2.06M	2.07M	2.12M	3.54M	3.54M	3.77M	3.91M	7.23M	8.43M	9.59M	21.72M	25.91M	27.93M	28.46M	40.25M	42.90M	43.13M	43.67M	52.59M	62.77M	63.82M	63.89M	79.21M	81.48M	81.59M	81.66M
Shares Outstanding (Diluted Average)																										3.54M	3.72M	3.56M	6.34M	8.11M	11.18M	11.92M	26.13M	27.76M	33.74M	32.09M	42.24M	43.25M	43.65M	44.76M	61.10M	63.85M	66.42M	67.89M	81.34M	81.59M	81.78M
EBITDA	-0.17M	-2.81M	-1.63M	-2.26M	-2.61M	-2.49M	-3.13M	-2.96M	-3.54M	-3.45M	-4.08M	-5.91M	-6.94M	-6.98M	-5.83M	-6.39M	-4.62M	-4.66M	-9.02M	-10.31M	-11.62M	-8.89M	-11.24M	-10.12M	-8.04M	-6.43M	-5.49M	-90.75M	-18.47M	-17.95M	-14.03M	-29.10M	-26.47M	-29.63M	-28.77M	-45.23M	-67.94M	-55.06M	-47.55M	-66.46M	-49.25M	-65.17M	-75.21M	-80.67M	-86.66M	-100.91M	-34.30M
Interest Expenses	0.54M	0.48M	0.00M	0.00M	0.02M	0.07M	0.02M	0.02M	0.09M	0.08M	0.08M	0.08M	0.07M	0.06M	0.06M	0.19M	0.21M	0.21M	0.22M	0.23M	0.23M	0.23M	0.20M	0.17M	0.14M	0.09M	0.09M	0.18M				0.00M		0.15M	0.16M	0.17M	0.17M	0.17M	0.60M	0.92M	0.59M	0.60M	0.53M	1.37M	0.59M	0.51M	0.56M
Shares Outstanding				0.25M				0.71M				0.74M								2.06M				2.32M	3.54M	3.54M	3.80M	4.23M	7.23M	8.61M	19.38M	23.92M	27.17M	28.46M

Research Tools

Viridian Therapeutics, Inc.\DE Income Statement (2014-2025) | VRDN

Create an account

Sign In

Reset Password

Get Pro for 60% off